Merit Medical Reports Modest Income Growth in Q4 2024

Merit Medical Systems shows positive momentum in its quarterly report. Net income increased moderately despite steady EPS, signaling potential for stock price stability and growth.

Date: 26-02-2025

AI Rating: 6

**Earnings per Share (EPS)**: Merit Medical maintained a steady EPS of $0.48, indicating stability in earnings performance. This can instill confidence among investors as it shows the company’s ability to sustain its profit levels.

**Net Income**: The net income saw a modest improvement to $27.95 million in Q4 2024, slightly up from $27.63 million in Q4 2023. Although the increase is marginal, it nonetheless reflects positive operational stability.

**Revenue Growth**: The company reported net sales of $355.2 million, which is a robust 9.4 percent increase compared to the previous year's $324.5 million. This growth in revenue can be a strong indication of increased market demand and effective sales strategies.

The stock closed at $102.03 on Nasdaq, a decrease of 1.43%, which may draw attention from investors looking for entry points despite the recent downturn.

Stocks: MMSI